These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1061 related items for PubMed ID: 17477859

  • 1. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.
    Jemal A, Ward E, Thun MJ.
    Breast Cancer Res; 2007; 9(3):R28. PubMed ID: 17477859
    [Abstract] [Full Text] [Related]

  • 2. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB, Feuer EJ, Harlan LC, Abrams J.
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [Abstract] [Full Text] [Related]

  • 3. Rising incidence rates of breast carcinoma with micrometastatic lymph node involvement.
    Cronin-Fenton DP, Ries LA, Clegg LX, Edwards BK.
    J Natl Cancer Inst; 2007 Jul 04; 99(13):1044-9. PubMed ID: 17596573
    [Abstract] [Full Text] [Related]

  • 4. Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival.
    Hill TD, Khamis HJ, Tyczynski JE, Berkel HJ.
    Ann Epidemiol; 2005 Nov 04; 15(10):773-80. PubMed ID: 16257362
    [Abstract] [Full Text] [Related]

  • 5. Changing patterns in breast cancer incidence trends.
    Holford TR, Cronin KA, Mariotto AB, Feuer EJ.
    J Natl Cancer Inst Monogr; 2006 Nov 04; (36):19-25. PubMed ID: 17032890
    [Abstract] [Full Text] [Related]

  • 6. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001.
    Li CI, Daling JR, Malone KE.
    Cancer Epidemiol Biomarkers Prev; 2005 Apr 04; 14(4):1008-11. PubMed ID: 15824180
    [Abstract] [Full Text] [Related]

  • 7. Decline in breast cancer incidence--United States, 1999-2003.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2007 Jun 08; 56(22):549-53. PubMed ID: 17557070
    [Abstract] [Full Text] [Related]

  • 8. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
    Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC, Friedman C, Harlan L, Warren J, Anderson RN, Pickle LW.
    J Natl Cancer Inst; 2005 Oct 05; 97(19):1407-27. PubMed ID: 16204691
    [Abstract] [Full Text] [Related]

  • 9. Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma.
    Anderson WF, Chu KC, Chang S, Sherman ME.
    Cancer Epidemiol Biomarkers Prev; 2004 Jul 05; 13(7):1128-35. PubMed ID: 15247123
    [Abstract] [Full Text] [Related]

  • 10. Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older.
    Li CI, Malone KE, Daling JR.
    Cancer Epidemiol Biomarkers Prev; 2002 Jul 05; 11(7):601-7. PubMed ID: 12101106
    [Abstract] [Full Text] [Related]

  • 11. Contemporary lung cancer trends among U.S. women.
    Jemal A, Ward E, Thun MJ.
    Cancer Epidemiol Biomarkers Prev; 2005 Mar 05; 14(3):582-5. PubMed ID: 15767333
    [Abstract] [Full Text] [Related]

  • 12. Geographic excess of estrogen receptor-positive breast cancer.
    Benz CC, Clarke CA, Moore DH.
    Cancer Epidemiol Biomarkers Prev; 2003 Dec 05; 12(12):1523-7. PubMed ID: 14693747
    [Abstract] [Full Text] [Related]

  • 13. Regional differences in the incidence and treatment of carcinoma in situ of the breast.
    Choi WS, Parker BA, Pierce JP, Greenberg ER.
    Cancer Epidemiol Biomarkers Prev; 1996 Apr 05; 5(4):317-20. PubMed ID: 8722225
    [Abstract] [Full Text] [Related]

  • 14. Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome.
    Anderson WF, Jatoi I, Devesa SS.
    Breast Cancer Res Treat; 2005 Mar 05; 90(2):127-37. PubMed ID: 15803359
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002.
    Coory M, Baade P, Aitken J, Smithers M, McLeod GR, Ring I.
    Cancer Causes Control; 2006 Feb 05; 17(1):21-7. PubMed ID: 16411049
    [Abstract] [Full Text] [Related]

  • 17. Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users.
    Kumar AS, Benz CC, Shim V, Minami CA, Moore DH, Esserman LJ.
    Cancer Epidemiol Biomarkers Prev; 2008 May 05; 17(5):1028-33. PubMed ID: 18463402
    [Abstract] [Full Text] [Related]

  • 18. Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations.
    Verkooijen HM, Koot VC, Fioretta G, van der Heiden M, Schipper ME, Rapiti E, Peeters PH, Peterse JL, Bouchardy C.
    Breast Cancer Res Treat; 2008 Feb 05; 107(3):389-95. PubMed ID: 17431760
    [Abstract] [Full Text] [Related]

  • 19. Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma.
    Grann VR, Troxel AB, Zojwalla NJ, Jacobson JS, Hershman D, Neugut AI.
    Cancer; 2005 Jun 01; 103(11):2241-51. PubMed ID: 15844176
    [Abstract] [Full Text] [Related]

  • 20. Five-year survival rates and time trends of laryngeal cancer in the US population.
    Cosetti M, Yu GP, Schantz SP.
    Arch Otolaryngol Head Neck Surg; 2008 Apr 01; 134(4):370-9. PubMed ID: 18427002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.